A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 11842294)

Published in J Allergy Clin Immunol on February 01, 2002

Authors

Iwona Stelmach1, Joanna Jerzynska, Piotr Kuna

Author Affiliations

1: Department of Pediatrics and Allergy, M. Curie Hospital, Zgierz, Poland.

Articles by these authors

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol (2013) 1.91

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med (2002) 1.90

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65

Risk factors for the development of atopic dermatitis and early wheeze. Allergy Asthma Proc (2014) 1.60

Aspirin intolerance and allergy to house dust mites: important factors associated with development of severe asthma. Ann Allergy Asthma Immunol (2004) 1.50

Montelukast treatment may alter the early efficacy of immunotherapy in children with asthma. J Allergy Clin Immunol (2010) 1.42

[Skin prick test with inhaled allergens in the general population of Lodz province]. Pneumonol Alergol Pol (2009) 1.41

Severe asthma attacks after sexual intercourse. Am J Respir Crit Care Med (2004) 1.40

Control of asthma in adults treated with beclomethasone and formoterol in extrafine particle formulation in a real-life setting in Poland: the CASPER noninterventional, observational trial. Pol Arch Med Wewn (2015) 1.39

Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol (2008) 1.33

The prevalence of mouse allergen in inner-city homes. Pediatr Allergy Immunol (2002) 1.09

Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma. J Allergy Clin Immunol (2007) 0.91

Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis. Exp Dermatol (2011) 0.90

Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses. J Allergy Clin Immunol (2011) 0.90

[The analysis of the factors influencing the development of glucocorticoid resistance in the etiopathogenesis of severe bronchial asthma]. Postepy Biochem (2010) 0.88

The N363S and I559N single nucleotide polymorphisms of the h-GR/NR3C1 gene in patients with bronchial asthma. Int J Mol Med (2012) 0.87

Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis. Neurol Neurochir Pol (2012) 0.86

The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis. Mediators Inflamm (2009) 0.86

[Epidemiology of atopic dermatitis in general population of the Lodz province's citizens]. Pneumonol Alergol Pol (2009) 0.86

Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review. Curr Med Res Opin (2011) 0.86

The effect of prenatal exposure to phthalates on food allergy and early eczema in inner-city children. Allergy Asthma Proc (2015) 0.86

A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma. Pulm Pharmacol Ther (2006) 0.85

The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot study. Mol Biol Rep (2010) 0.85

The role of zinc, copper, plasma glutathione peroxidase enzyme, and vitamins in the development of allergic diseases in early childhood: The Polish mother and child cohort study. Allergy Asthma Proc (2014) 0.85

Protective effect of the KIR2DS1 gene in atopic dermatitis. Gene (2013) 0.84

[Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications]. Pneumonol Alergol Pol (2009) 0.84

Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. Pediatr Allergy Immunol (2006) 0.84

A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma. Respir Med (2010) 0.84

[MicroRNAs--new biomarkers of respiratory tract diseases]. Pneumonol Alergol Pol (2014) 0.83

The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma. Pulm Pharmacol Ther (2005) 0.83

Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis. Am J Rhinol Allergy (2013) 0.83

Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. Respirology (2006) 0.81

Measurement of specific airway resistance decreased the risk of delay in asthma diagnosis in children. Allergy Asthma Proc (2009) 0.81

Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge. Respir Med (2010) 0.81

Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes. Exp Ther Med (2012) 0.81

The role of functional single nucleotide polymorphisms of the human glucocorticoid receptor gene NR3C1 in Polish patients with bronchial asthma. Mol Biol Rep (2011) 0.81

The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy. Respir Res (2012) 0.80

Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis. Ann Allergy Asthma Immunol (2005) 0.80

Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol (2004) 0.80

[Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children]. Pol Merkur Lekarski (2002) 0.80

The effect of 4 weeks treatment with desloratadine (5mg daily) on levels of interleukin (IL)-4, IL-10, IL-18 and TGF beta in patients suffering from seasonal allergic rhinitis. Pulm Pharmacol Ther (2006) 0.80

[Epidemics of allergic diseases: a new health problem in the modern world]. Pol Merkur Lekarski (2003) 0.80

Long-term deterioration of lung function in asthmatic outpatients. Respiration (2004) 0.79

The effect of inhaled heparin on airway responsiveness to histamine and leukotriene D4. Allergy Asthma Proc (2003) 0.79

MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis. Arch Med Sci (2013) 0.78

[IL-10 serum levels in children with moderate asthma]. Pneumonol Alergol Pol (2002) 0.78

The Global Alliance against Respiratory Diseases (GARD) Country Report. Prim Care Respir J (2014) 0.78

Two patterns of changes in nasal nitric oxide after lysine aspirin nasal challenge in patients with aspirin-exacerbated respiratory disease. Am J Rhinol Allergy (2012) 0.77

Impact of chronic obstructive pulmonary disease (COPD) on patient's life and his family. Pneumonol Alergol Pol (2014) 0.77

[Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge]. Pneumonol Alergol Pol (2002) 0.77

The ECP/Eo count ratio in children with asthma. J Asthma (2004) 0.77

[Lack of correlation between exhaled nitric oxide (eNO) and clinical indicators of the disease activity and quality of life in mild and moderate asthmatics]. Pneumonol Alergol Pol (2006) 0.77

[The effect of inhaled heparin on post-leukotriene bronchoconstriction in children with bronchial asthma]. Pol Merkur Lekarski (2002) 0.76

The NR3C1 Glucocorticoid Receptor Gene Polymorphisms May Modulate the TGF-beta mRNA Expression in Asthma Patients. Inflammation (2015) 0.76

Effect of inhaled steroid and montelukast on clinical symptoms in children with newly diagnosed asthma: a pilot study. Pediatr Allergy Immunol (2010) 0.76

[Acoustic rhinometry in the evaluation of intranasal aspirin challenge]. Pneumonol Alergol Pol (2010) 0.76

[Prevalence of atopy and atopic diseases in children living in an orphanage in Lodz area--pilot study]. Pol Merkur Lekarski (2006) 0.76

Identification and association of TGFβ-1 expression in patients with asthma in a Polish population - Lodz metropolitan area study. Int J Biochem Mol Biol (2013) 0.76

[The effect of triamcinolone acetonide, montelukast, nedocromil sodium, formoterol on levels levels of sICAM-1, sIL-2R in serum and clinical course of asthma in children]. Pol Merkur Lekarski (2002) 0.76

[The use of multi-color flow cytometry for identification of functional markers of nTregs in patients with severe asthma]. Pneumonol Alergol Pol (2012) 0.76

Decreased markers of atopy in children with presumed early exposure to allergens, unhygienic conditions, and infections. Ann Allergy Asthma Immunol (2007) 0.75

Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study. Pediatr Allergy Immunol (2004) 0.75

Life threatening pneumonia in a lupus patient: a case report. Cases J (2008) 0.75

Inhaled corticosteroids may have a beneficial effect on bone metabolism in newly diagnosed asthmatic children. Pulm Pharmacol Ther (2011) 0.75

[Level of interleukin-12 and interferon gamma in blood serum of children with neoplasms and allergy]. Pol Merkur Lekarski (2005) 0.75

[Basophil degranulation test in the diagnosis of nonsteroidal anti-inflammatory drug hypersensitivity]. Pol Merkur Lekarski (2005) 0.75

Adhesion molecules and their ligands in nasal polyps of aspirin-hypersensitive patients. Ann Allergy Asthma Immunol (2006) 0.75

[Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties]. Pol Merkur Lekarski (2002) 0.75

Frequencies of Bcl I, E22E, and N363S of h-GR/NR3C1 restriction fragment length polymorphisms of glucocorticoid receptor gene in Polish adult population. Med Sci Monit (2010) 0.75

[Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study]. Pneumonol Alergol Pol (2006) 0.75

[Bronchial asthma--epidemiology, public and economic problems]. Pol Merkur Lekarski (2002) 0.75

[Precision and economy of skin prick tests]. Pol Merkur Lekarski (2002) 0.75

[Exploring new therapeutic approaches to the treatment of inflammatory disorders--lipoxins]. Pol Merkur Lekarski (2005) 0.75

[The role of interleukin 10 in allergic inflammation]. Pol Merkur Lekarski (2005) 0.75

[Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action]. Pol Merkur Lekarski (2002) 0.75

[The effect of desloratadine on use of rescue beta2-agonists and symptoms in patients suffering from seasonal allergic rhinitis and asthma]. Pol Merkur Lekarski (2005) 0.75

[Cockroach hypersensitivity in children suffering from perennial allergic rhinitis]. Pol Merkur Lekarski (2005) 0.75

High exposure to passive tobacco smoking and the development of asthma in an adult patient who had never smoked. Am J Respir Crit Care Med (2010) 0.75

[Asthma as a mask of other respiratory diseases]. Wiad Lek (2006) 0.75

[Intensity of depression in pedagogy students]. Pol Merkur Lekarski (2012) 0.75

The effect of montelukast (10mg daily) and loratadine (10mg daily) on wheal, flare and itching reactions in skin prick tests. Pulm Pharmacol Ther (2006) 0.75

Ranitidine (150 mg daily) inhibits wheal, flare, and itching reactions in skin-prick tests. Allergy Asthma Proc (2008) 0.75

[The underdiagnosis and undertreatment of asthma in general population of the Lodz Province (Poland)]. Pneumonol Alergol Pol (2010) 0.75

[Diagnosis and therapy of chronic obstructive pulmonary disease--recommendations of the Polish Phtisiopneumonology Society]. Pneumonol Alergol Pol (2002) 0.75

Selected bone morphogenetic proteins - the possibility of their use in the diagnostics and therapy of severe asthma. Adv Respir Med (2017) 0.75

[The influence of mononucleosis infection on atopic disease development in children]. Pneumonol Alergol Pol (2005) 0.75

[Aspirin and other nonsteroidal anti-inflammatory drugs hypersensitivity--mechanisms, diagnostics and treatment]. Pneumonol Alergol Pol (2008) 0.75

Do we need the specialty of internal medicine? Pol Arch Med Wewn (2016) 0.75

[The Churg-Strauss syndrome and antileukotriene agents]. Pol Merkur Lekarski (2005) 0.75

A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children. Ann Allergy Asthma Immunol (2002) 0.75

[Cockroach allergen Bla g 2 levels in houses in Lodz]. Pol Merkur Lekarski (2002) 0.75

[Role of ciclesonide in asthma therapy]. Pneumonol Alergol Pol (2008) 0.75

Knowledge of medical law amongst doctors of internal diseases. Int J Occup Med Environ Health (2013) 0.75